Analysts Predict Exciting Upside for USXF and Its Holdings

Analysts foresee a bright future for USXF, with a projected upside of 22.72% over the next 12 months based on its holdings. The forecast presents a solid investment opportunity that could impact stock prices positively.

Date: 05-03-2025

AI Rating: 7

Implied Analyst Target Prices Indicate Growth Potential

The report discusses the comparison between the current trading prices of the iShares ESG Advanced MSCI USA ETF (USXF) and its underlying holdings, revealing significant upside potential based on analyst target prices. The ETF is currently trading at $48.68, with an implied target price of $59.74, indicating a promising 22.72% upside.

Notable Holdings with Upside

Among the underlying assets in the ETF, three notable companies show impressive upside potential:

Bio-Rad Laboratories Inc (BIO): Currently trading at $256.45 with an average target price of $382.40, showcasing a 49.11% upside.
Hubbell Inc. (HUBB): Trading at $354.95 with a target price of $472.56, leading to a potential 33.13% upside.
GE Vernova Inc (GEV): Recently priced at $315.98, with analysts targeting $419.92, suggesting a 32.89% upside.

These figures illustrate analyst optimism regarding these companies’ stock performances, making them attractive for investors looking at growth opportunities.

Considerations on Analyst Targets

While the high target prices relative to current trading prices suggest robust future performance, it raises questions about analysts’ accuracy. Investors must assess if these targets are genuinely justified by recent developments in these companies or if they reflect outdated perspectives. A high target may indicate optimism but could lead to adjustments if expectations are too optimistic.

Stocks: USXF BIO HUBB GEV